Magnani M, Stocchi V, Cucchiarini L, Chiarantini L, Fornaini G
Cell Biochem Funct. 1986 Oct;4(4):263-9. doi: 10.1002/cbf.290040406.
Red blood cells exposed in vitro to phenylhydrazine acquired Heinz bodies, bound autologous IgG and were then phagocytized when incubated with autologus mononuclear phagocytes. In vivo, phenylhdyrazine administered to rabbits, caused the appearance of high plasma hemoglobin levels and hemoglobinuria as well as Heinz body formations and IgG binding to erythrocytes. This suggests that while in vitro the main mechanism of red cell removal seems to be phagocytoses, in vivo both intravascular hemolysis and phagocytosis are active processes. Preliminary biochemical studies on phenylhydrazine-exposed erythrocytes showed that together with the well-known appearance of Heinz bodies, methemoglobin and a drop in reduced glutathione, this drug also causes ATP depletion. This is initially concomitant with the appearance of ADP and AMP and subsequently hypoxantine. Thus, irreversible ATP depletion may contribute to the genesis of the hemolytic process observed in vivo.
体外暴露于苯肼的红细胞会形成海因茨小体,结合自身免疫球蛋白G,随后与自身单核吞噬细胞一起孵育时会被吞噬。在体内,给兔子注射苯肼会导致血浆血红蛋白水平升高、血红蛋白尿以及海因茨小体形成和免疫球蛋白G与红细胞结合。这表明,虽然在体外红细胞清除的主要机制似乎是吞噬作用,但在体内血管内溶血和吞噬作用都是活跃过程。对暴露于苯肼的红细胞进行的初步生化研究表明,除了众所周知的海因茨小体出现、高铁血红蛋白生成和还原型谷胱甘肽水平下降外,这种药物还会导致三磷酸腺苷(ATP)耗竭。这最初与二磷酸腺苷(ADP)和一磷酸腺苷(AMP)的出现同时发生,随后是次黄嘌呤。因此,不可逆的ATP耗竭可能有助于体内观察到的溶血过程的发生。